IL5 and asthma: Another cluster analysis identified two clusters that carried a predominantly type 2 signature (which included high levels of IL-5, IL-4, and IL-13), with all patients having CRSwNP, a high frequency of comorbid asthma (>80%), high disease burden including smell impairment, and a high incidence of surgery (20).